Horizon Therapeutics

$70.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.65 (+2.39%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell HZNP and other stocks, options, and ETFs commission-free!

About HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares, also called Horizon Therapeutics, is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. The listed name for HZNP is Horizon Therapeutics Public Limited Company Ordinary Shares.

CEO
Timothy P. Walbert
Employees
1,200
Headquarters
Dublin, Dublin
Founded
2008
Market Cap
15.57B
Price-Earnings Ratio
19.26
Dividend Yield
Average Volume
2.29M
High Today
$70.98
Low Today
$69.74
Open Price
$69.74
Volume
2.36M
52 Week High
$86.67
52 Week Low
$23.81

Collections

HZNP Earnings

$0.00
$0.58
$1.16
$1.74
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 24, Pre-Market

You May Also Like